Heinrich Scheiblauer

1.0k total citations
20 papers, 668 citations indexed

About

Heinrich Scheiblauer is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Heinrich Scheiblauer has authored 20 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 11 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Heinrich Scheiblauer's work include Hepatitis B Virus Studies (12 papers), Hepatitis C virus research (11 papers) and Liver Disease Diagnosis and Treatment (7 papers). Heinrich Scheiblauer is often cited by papers focused on Hepatitis B Virus Studies (12 papers), Hepatitis C virus research (11 papers) and Liver Disease Diagnosis and Treatment (7 papers). Heinrich Scheiblauer collaborates with scholars based in Germany, United States and United Kingdom. Heinrich Scheiblauer's co-authors include R. Rott, Masato Tashiro, M. Reinacher, Sigrid Nick, C. Micha Nübling, Heinz Zeichhardt, A. M. Prince, Alan P. Kendal, Michael Schmidt and Erhard Seifried and has published in prestigious journals such as Hepatology, The Journal of Infectious Diseases and Virology.

In The Last Decade

Heinrich Scheiblauer

20 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heinrich Scheiblauer Germany 12 469 290 221 55 53 20 668
Azumi Ishizaki Japan 16 461 1.0× 298 1.0× 221 1.0× 84 1.5× 40 0.8× 36 709
Ulrike C. Wend Germany 17 980 2.1× 934 3.2× 171 0.8× 60 1.1× 18 0.3× 28 1.1k
Kate I. Tettmar United Kingdom 10 191 0.4× 608 2.1× 359 1.6× 35 0.6× 12 0.2× 17 774
Robin A. Gutierrez United States 14 653 1.4× 784 2.7× 267 1.2× 58 1.1× 15 0.3× 28 1.0k
Ariadna Rando‐Segura Spain 13 342 0.7× 267 0.9× 215 1.0× 52 0.9× 12 0.2× 75 605
Thoai Duong Ly France 12 262 0.6× 171 0.6× 343 1.6× 39 0.7× 19 0.4× 14 581
M. K. Hourfar Germany 18 333 0.7× 237 0.8× 329 1.5× 70 1.3× 52 1.0× 26 827
Huub C. Gelderblom United States 14 193 0.4× 190 0.7× 155 0.7× 64 1.2× 34 0.6× 27 517
Mikihiro Yunoki Japan 14 115 0.2× 186 0.6× 344 1.6× 64 1.2× 8 0.2× 38 524
Michael Chudy Germany 19 711 1.5× 668 2.3× 362 1.6× 54 1.0× 10 0.2× 36 1.0k

Countries citing papers authored by Heinrich Scheiblauer

Since Specialization
Citations

This map shows the geographic impact of Heinrich Scheiblauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heinrich Scheiblauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heinrich Scheiblauer more than expected).

Fields of papers citing papers by Heinrich Scheiblauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heinrich Scheiblauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heinrich Scheiblauer. The network helps show where Heinrich Scheiblauer may publish in the future.

Co-authorship network of co-authors of Heinrich Scheiblauer

This figure shows the co-authorship network connecting the top 25 collaborators of Heinrich Scheiblauer. A scholar is included among the top collaborators of Heinrich Scheiblauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heinrich Scheiblauer. Heinrich Scheiblauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heitmann, Anna, Markus B. Funk, Jonas Schmidt‐Chanasit, et al.. (2025). Assessment of the effectiveness of West Nile virus screening by analysing suspected positive donations among blood donors, Germany, 2020 to 2023. Eurosurveillance. 30(8). 3 indexed citations
2.
Buchta, Christoph, Vincent Delatour, Andrea Griesmacher, et al.. (2024). Reference, calibration and referral laboratories – a look at current European provisions and beyond. Clinical Chemistry and Laboratory Medicine (CCLM). 63(4). 656–669. 1 indexed citations
3.
4.
Scheiblauer, Heinrich, et al.. (2022). Sicherheit von Blut und Blutprodukten: Testmethoden zum Nachweis der Hepatitisviren B, C und E. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 65(2). 209–219. 1 indexed citations
5.
Scheiblauer, Heinrich, Andreas Nitsche, Andreas Puyskens, et al.. (2021). Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021. Eurosurveillance. 26(44). 73 indexed citations
6.
Scheiblauer, Heinrich, C. Micha Nübling, Timo Wolf, et al.. (2021). Antibody response to SARS-CoV-2 for more than one year − kinetics and persistence of detection are predominantly determined by avidity progression and test design. Journal of Clinical Virology. 146. 105052–105052. 28 indexed citations
7.
Scheiblauer, Heinrich, M. Heiden, Markus B. Funk, et al.. (2020). Detection of hepatitis B virus infection in German blood donors 2008–2015. Vox Sanguinis. 115(3). 152–161. 4 indexed citations
8.
Henß, Lisa, Tatjana Scholz, Christine von Rhein, et al.. (2020). Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. The Journal of Infectious Diseases. 223(1). 56–61. 42 indexed citations
9.
10.
Peiffer, Kai‐Henrik, Dieter Glebe, Andreas Reuter, et al.. (2016). Comparative characterization of hepatitis B virus surface antigen derived from different hepatitis B virus genotypes. Virology. 502. 1–12. 22 indexed citations
11.
Wilkinson, Dianna E., Pia L. Seiz, Christian G. Schüttler, et al.. (2016). International collaborative study on the 3rd WHO International Standard for hepatitis B surface antigen. Journal of Clinical Virology. 82. 173–180. 9 indexed citations
12.
Only, English, et al.. (2013). Collaborative Study to Establish a World Health Organization International Standard for Hepatitis B e Antigen (HBeAg). 4 indexed citations
13.
Chudy, M., Heinrich Scheiblauer, K.‐M. Hanschmann, et al.. (2013). Performance of hepatitis B surface antigen tests with the first WHO international hepatitis B virus genotype reference panel. Journal of Clinical Virology. 58(1). 47–53. 27 indexed citations
14.
15.
Schmidt, Michael, C. Micha Nübling, Heinrich Scheiblauer, et al.. (2006). Anti‐HBc screening of blood donors: a comparison of nine anti‐HBc tests. Vox Sanguinis. 91(3). 237–243. 57 indexed citations
16.
Scheiblauer, Heinrich, et al.. (2006). Evaluation of the performance of 44 assays used in countries with limited resources for the detection of antibodies to hepatitis C virus. Transfusion. 46(5). 708–718. 31 indexed citations
17.
Chudy, Michael, Michael Schmidt, Heinrich Scheiblauer, et al.. (2006). Hepatitis B virus genotype G monoinfection and its transmission by blood components. Hepatology. 44(1). 99–107. 52 indexed citations
18.
Willkommen, Hannelore, Heinrich Scheiblauer, & Johannes Löwer. (1999). Serum and serum substitutes: virus safety by inactivation or removal.. PubMed. 99. 131–8. 9 indexed citations
19.
Scheiblauer, Heinrich, Alan P. Kendal, & R. Rott. (1995). Pathogenicity of influenza A/Seal/Mass/1/80 virus mutants for mammalian species. Archives of Virology. 140(2). 341–348. 43 indexed citations
20.
Scheiblauer, Heinrich, M. Reinacher, Masato Tashiro, & R. Rott. (1992). Interactions between Bacteria and Influenza A Virus in the Developmentof Influenza Pneumonia. The Journal of Infectious Diseases. 166(4). 783–791. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Azumi Ishizaki Breakdown of academic impact, for papers by Ulrike C. Wend Breakdown of academic impact, for papers by Kate I. Tettmar Breakdown of academic impact, for papers by Robin A. Gutierrez Breakdown of academic impact, for papers by Ariadna Rando‐Segura Breakdown of academic impact, for papers by Thoai Duong Ly Breakdown of academic impact, for papers by M. K. Hourfar Breakdown of academic impact, for papers by Huub C. Gelderblom Breakdown of academic impact, for papers by Mikihiro Yunoki Breakdown of academic impact, for papers by Michael Chudy
Rankless by CCL
2026